GYRE
NASDAQGyre Therapeutics Inc.
Price$6.05-0.07 (-1.14%)
01:30 PM07:45 PM
News · 26 weeks52+11%
2026-01-252026-07-19
Mix4290d
- Insider24(57%)
- SEC Filings14(33%)
- Other2(5%)
- Earnings1(2%)
- Leadership1(2%)
Latest news
25 items- SECGyre Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
- PRGyre Therapeutics Appoints Three New Members to its Board of DirectorsSAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. ("Gyre", "Gyre Therapeutics" or the "Company") (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that its Board of Directors has appointed three new members, effective August 1, 2026: Yue Xiong, Ph.D., the Company's Chief Scientific Officer; Maxwell ("Max") Kirkby; and Claire Weston, Ph.D. With these appointments, the Board expands its scientific, clinical development, and cross-border biopharmaceutical operating expertise as Gyre advances its broad pipeline of products targeting numerous therapeutic areas including fibrosis, cancer, in
- SECAmendment: Gyre Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K/A - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
- SECAmendment: SEC Form S-3/A filed by Gyre Therapeutics Inc.S-3/A - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
- INSIDERSEC Form 4 filed by Director Carmichael Gordon4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Director Weng Dan4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Director Zhang Ping4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Director Parry Renate4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Director Epstein David M.4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Director Nussbaum Rodney L4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERChief Operating Officer Ye Weiguo exercised 11,000 shares at a strike of $0.75 and sold $68,700 worth of shares (11,000 units at $6.25) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- SECGyre Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
- INSIDERChief Operating Officer Ye Weiguo exercised 2,800 shares at a strike of $0.75 and sold $17,276 worth of shares (2,800 units at $6.17) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERChief Operating Officer Ye Weiguo exercised 20,918 shares at a strike of $0.75 and sold $128,886 worth of shares (20,918 units at $6.16) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by GC and Corporate Secretary Bergmann Joshua Benjamin4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Chief Executive Officer Luo Ying4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- SECSEC Form S-8 filed by Gyre Therapeutics Inc.S-8 - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
- INSIDERChief Operating Officer Ye Weiguo exercised 34,976 shares at a strike of $0.75 and sold $218,561 worth of shares (34,976 units at $6.25) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- SECGyre Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
- INSIDERChief Operating Officer Ye Weiguo exercised 7,500 shares at a strike of $0.75 and sold $45,680 worth of shares (7,500 units at $6.09) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERChief Operating Officer Ye Weiguo exercised 22,220 shares at a strike of $0.75 and sold $136,653 worth of shares (22,220 units at $6.15) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERSEC Form 4 filed by Director Zhang Ping4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERChief Operating Officer Ye Weiguo exercised 9,320 shares at a strike of $0.75 and sold $59,418 worth of shares (9,320 units at $6.38) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- INSIDERChief Operating Officer Ye Weiguo exercised 28,680 shares at a strike of $0.75 and sold $194,773 worth of shares (28,680 units at $6.79) (SEC Form 4)4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
- SECGyre Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
GYRE FAQ
6 questionsWhere does GYRE stock trade?
Gyre Therapeutics Inc. (GYRE) is listed on NASDAQ.What sector and industry is GYRE in?
Gyre Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Gyre Therapeutics Inc. go public?
Gyre Therapeutics Inc. (GYRE) completed its IPO in 2006.What are analysts saying about GYRE?
Gyre Therapeutics Inc. has had 3 recent analyst actions on file. The most recent action was from Jefferies: Buy with a $1600.00 price target on 2025-10-10. Recent price targets range from $1600.00 to $1800.00.What companies are similar to GYRE?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare GYRE side-by-side with any of them on Quantisnow.How can I track GYRE on Quantisnow?
Quantisnow aggregates Gyre Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GYRE to receive live email and push alerts on every new disclosure.